Abstract: Methods for screening for altered focal proliferation states in non-pregnant patients, which include detecting levels of pregnancy-associated plasma protein-A (PAPP-A) are described. Methods for identifying agents that alter the protease activity of PAPP-A, and pharmaceutical compositions and medical devices that include such agents are also described.
Type:
Grant
Filed:
March 15, 2000
Date of Patent:
October 3, 2006
Assignees:
Mayo Foundation for Medical Education and Research, Como Holdings APS
Inventors:
Michael Toft Overgaard, Claus Oxvig, Cheryl A. Conover